↓ Skip to main content

Low dose naltrexone for induction of remission in Crohn's disease

Overview of attention for article published in Cochrane database of systematic reviews, February 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

policy
1 policy source
twitter
24 tweeters
facebook
4 Facebook pages

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
72 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Low dose naltrexone for induction of remission in Crohn's disease
Published in
Cochrane database of systematic reviews, February 2014
DOI 10.1002/14651858.cd010410.pub2
Pubmed ID
Authors

Dan Segal, John K MacDonald, Nilesh Chande

Abstract

Crohn's disease is a transmural, relapsing inflammatory condition afflicting the digestive tract. Opioid signalling, long known to affect secretion and motility in the gut, has been implicated in the inflammatory cascade of Crohn's disease. Low dose naltrexone, an opioid antagonist, has garnered interest as a potential therapy.

Twitter Demographics

The data shown below were collected from the profiles of 24 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 3%
Chile 1 1%
Brazil 1 1%
Unknown 68 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 14 19%
Student > Doctoral Student 9 13%
Student > Postgraduate 7 10%
Researcher 7 10%
Student > Bachelor 7 10%
Other 18 25%
Unknown 10 14%
Readers by discipline Count As %
Medicine and Dentistry 28 39%
Nursing and Health Professions 9 13%
Psychology 6 8%
Agricultural and Biological Sciences 5 7%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Other 7 10%
Unknown 14 19%

Attention Score in Context

This research output has an Altmetric Attention Score of 18. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 December 2019.
All research outputs
#1,170,507
of 16,427,352 outputs
Outputs from Cochrane database of systematic reviews
#3,136
of 11,496 outputs
Outputs of similar age
#15,490
of 191,058 outputs
Outputs of similar age from Cochrane database of systematic reviews
#67
of 205 outputs
Altmetric has tracked 16,427,352 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,496 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.3. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 191,058 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 205 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.